AndhraNews.net
Home » Business News » 2012 » December » December 18, 2012

Medecision Awarded Full NCQA Disease Management Systems Certification


December 18, 2012 - Wayne, PA

Medecision, the leader in collaborative healthcare management technology, today announced that it has earned National Committee for Quality Assurance (NCQA) Disease Management Systems Certification for the full suite of Aerial™ solutions including Disease Management (DM) Clinical Programs.

NCQA is an independent, not-for-profit organization dedicated to measuring the quality of America's healthcare. According to NCQA, employers select NCQA-certified DM programs because they are proven to provide evidence-based information and systems to support DM programs and they raise the bar by addressing patient safety and improving services.

NCQA-certified DM programs improve patient safety and health outcomes, decrease associated costs, and reduce inconsistencies in service delivery.

This distinction makes the Aerial care management platform a powerful solution set with full Disease Management certification, which covers asthma, CAD, cardiovascular disease, CHF, COPD, depression, diabetes, high-risk pregnancy, HIV, hypertension, inflammatory bowel disease, lower back pain, obesity, PAD, and renal disease. The certification covers the entire Aerial solutions suite, including Analytics, Clinical Programs, and the iExchange provider portal.

The NCQA evaluation program offers certification for organizations that provide specific DM functions as well as Clinical Analytics identification. These standards build on NCQA's years of accreditation and certification experience, detailed market research, and input from industry experts and other stakeholders.

"We're very proud to have earned this NCQA certification," said Katherine Schneider, MD, M.Phil., FAAFP, executive vice president and chief medical officer, Medecision. "It is a key consideration for our customers, and it serves as proof that the Aerial platform is built with evidence-based care at its core. As we execute our vision for connected care everywhere, our NCQA certification gives our customers added confidence that Aerial allows them to lead the way toward collaborative, patient-centered care."

The NCQA Disease Management Systems Certification is in addition to Medecision's existing NCQA certification for Healthcare Effectiveness Data and Information Set (HEDIS) software for the solution's ability to help healthcare organizations proactively identify opportunities to improve member health through interventions based on evidence-based medicine.

"Earning NCQA Disease Management Certification indicates that a DM program excels in the specific area in which it was reviewed, program design, patient outreach, or DM systems. It's an accomplishment to be proud of," said NCQA President Margaret E. O'Kane.

About Medecision
Medecision is the leading provider of healthcare management solutions serving national, regional and local health plans, insurers and care delivery organizations, more than 74,000 physicians and 44 million consumers. Working within the framework that patients, care providers and health plans are all driving towards better health outcomes, Medecision and its Aerial™ solution helps connect all stakeholders to liberate the highest quality and most cost-efficient care.

As more organizations transition to value-based care, Medecision continually applies its 24 years of experience, its comprehensive technology platforms, significant investments in research and development, and the broadest implementation and clinical expertise to ensure consumers receive the best possible care. With Medecision as a business partner, health plans and care providers confidently manage through market changes, regulatory updates, and new populations, while improving quality and reducing costs.

Medecision is a trademark of Medecision, Inc. The Medecision logo and product names are also trademarks or registered trademarks of Medecision, Inc. Other product and brand names are trademarks of their respective owners.

Add to Digg Bookmark with del.icio.us Add to Newsvine

MarketWire

Comment on this story

Share